Rat VEGF Antibody

Catalog # Availability Size / Price Qty
AF564
AF564-SP
VEGF164in Rat Kidney.
8 Images
Product Details
Citations (44)
FAQs
Supplemental Products
Reviews

Rat VEGF Antibody Summary

Species Reactivity
Rat
Specificity
Detects rat VEGF in direct ELISAs and Western blots. In direct ELISAs, approximately 20% cross-reactivity with recombinant human (rh) VEGF165 and rhVEGF121 is observed and less than 2% cross-reactivity with rhVEGF-B, recombinant mouse (rm) VEGF-B, rhVEGF-C, rhVEGF-D, and rmVEGF-D is observed. In Western blots, detection of recombinant mouse VEGF165 is observed.
Source
Polyclonal Goat IgG
Purification
Antigen Affinity-purified
Immunogen
Mouse myeloma cell line NS0-derived recombinant rat VEGF164
Ala27-Arg190
Accession # AAL07526
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Endotoxin Level
<0.10 EU per 1 μg of the antibody by the LAL method.
Label
Unconjugated

Applications

Recommended Concentration
Sample
Western Blot
0.1 µg/mL
See below
Immunohistochemistry
5-15 µg/mL
See below
Neutralization
Measured by its ability to neutralize VEGF164-induced proliferation in HUVEC human umbilical vein endothelial cells. The Neutralization Dose (ND50) is typically 0.2-0.6 µg/mL in the presence of 20 ng/mL Recombinant Rat VEGF164.

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Immunohistochemistry VEGF<sub>164</sub>in Rat Kidney. View Larger

VEGF164in Rat Kidney. VEGF164was detected in perfusion fixed frozen sections of rat kidney using 15 µg/mL Goat Anti-Rat VEGF164Antigen Affinity-purified Polyclonal Antibody (Catalog # AF564) overnight at 4 °C. Tissue was stained with the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS008) and counterstained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Frozen Tissue Sections.

Neutralization Cell Proliferation Induced by VEGF<SUB>164</SUB>and Neutralization by Rat VEGF Antibody. View Larger

Cell Proliferation Induced by VEGF164and Neutralization by Rat VEGF Antibody. Recombinant Rat VEGF164(Catalog # 564-RV) stimulates proliferation in HUVEC human umbilical vein endothelial cells in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Rat VEGF164(20 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Rat VEGF 164 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF564). The ND50 is typically 0.2-0.6 µg/mL.

Western Blot Detection of Recombinant Rat and Mouse VEGF antibody by Western Blot. View Larger

Detection of Recombinant Rat and Mouse VEGF by Western Blot. Western blot shows 25 ng of Recombinant Rat VEGF 164 (Catalog # 564-RV), Recombinant Human VEGF 165 (Catalog # 293-VE) and Recombinant Mouse VEGF 164 (Catalog # 493-MV). PVDF Membrane was probed with 0.1 µg/mL of Goat Anti-Rat VEGF 164 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF564) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF109). A specific band was detected for VEGF at approximately 20-25 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 3.This antibody does not detect natural VEGF in lysates from cell lines or tissues.

Immunohistochemistry Detection of Porcine VEGF by Immunohistochemistry View Larger

Detection of Porcine VEGF by Immunohistochemistry Expression of proteins relevant to kidney regeneration in female MWF rats.Immunohistochemical staining of VEGF in female animals receiving saline or MET transplant, after 6 weeks. Scale bars = 50 μm. Representative immunofluorescence staining (red) of FGF2, HGF, IGF-1 and Pax-2 in female rats receiving saline or MET, on renal tissues labeled with WGA-lectin (green) and DAPI (blue). Scale bars = 50 μm, = 25 μm (for FGF2 and IGF-1). Semiquantitative analysis of immunohistochemical stainings of VEGF, FGF2, HGF, IGF-1 and Pax-2 in female MWF rats receiving saline or MET. Data are expressed as mean ± SE (n = 3/group). Image collected and cropped by CiteAb from the following open publication (https://dx.plos.org/10.1371/journal.pone.0120235), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of Porcine VEGF by Western Blot View Larger

Detection of Porcine VEGF by Western Blot Depletion of BAMs attenuates ischemia-induced pial and cortical vascular permeability. BAMs were depleted by i.c.v. administration of clodronate liposomes (CL) 4 days prior to ischemia. For treatment control, rats received vehicle liposomes (V). a) Vegfa mRNA was studied in cortical and subcortical regions of the ipsilateral (ipsi, ischemic) and the contralateral (contra) brain hemispheres. Ischemia-induced expression of Vegfa mRNA at 24 h is attenuated in the cortex of the CL rats versus the V rats (n = 6 per group) (Mann Whitney test, p = 0.041). b) Western blotting of cortical and subcortical brain tissue (ipsilateral) 24 h post-ischemia shows the VEGF164 isoform of VEGF-A detected as two bands corresponding to the homodimeric and monomeric forms at approximately 54 kDa and 24 kDa. Quantification of signal intensity of the 54-kDa band shows reduced expression in the cortex of rats receiving CL vs. rats receiving V (n = 6 per group) (Mann-Whitney test, **p = 0.002). c) Ischemia increases the permeability of pial vessels (arrows), as assessed by Evans blue extravasation 24 h post-ischemia, and BAM depletion attenuates the effect. Images of one representative coronal brain section per rat of each treatment group show Evans blue extravasation in the ipsilateral hemisphere. Rats receiving clodronate show negligible Evans blue in the cortex (arrows in the schematic representation at the right hand side). The volume of tissue showing Evans blue extravasation is reduced in the cortex, but not in subcortical zones, of the CL group (n = 8) versus the V group (n = 7) (Mann-Whitney test, *p = 0.014). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/30092836), licensed under a CC-BY license. Not internally tested by R&D Systems.

Immunohistochemistry Detection of Porcine VEGF by Immunohistochemistry View Larger

Detection of Porcine VEGF by Immunohistochemistry Expression of mRNAs and proteins relevant to kidney regeneration in male MWF rats.(A) Real Time RT-PCR analysis of VEGF, FGF2, HGF, IGF-1 and Pax-2 in whole host renal tissues of male MWF rats receiving saline or metanephroi (MET) (in adjacent area), 6 weeks after transplantation. Data are expressed as mean ± SE; *P < 0.05, **P < 0.01 vs saline (n = 4 rats/group, VEGF n = 6 rats/group). (B) Immunohistochemical staining of VEGF (arrows) in male animals receiving saline or MET transplant, after 6 weeks. Scale bars = 50 μm. Representative immunofluorescence stainings (red) of FGF2, HGF, IGF-1 and Pax-2 in rats receiving saline or MET, on renal tissues labeled with WGA-lectin (green) and DAPI (blue). Scale bars = 50 μm, = 25 μm (for FGF2 and IGF-1). Semiquantitative analysis of immunohistochemical staining of VEGF, FGF2, HGF, IGF-1 and Pax-2 in male MWF rats receiving saline or MET. Data are expressed as mean ± SE; *P < 0.05, **P < 0.01 vs saline (n = 3/group). Image collected and cropped by CiteAb from the following open publication (https://dx.plos.org/10.1371/journal.pone.0120235), licensed under a CC-BY license. Not internally tested by R&D Systems.

Immunocytochemistry/ Immunofluorescence Detection of Porcine VEGF by Immunocytochemistry/ Immunofluorescence View Larger

Detection of Porcine VEGF by Immunocytochemistry/ Immunofluorescence Effect of fibroblasts transplanted under the kidney capsule of male MWF rats.(A) Histological appearance of renal tissue from male MWF rat transplanted with fibroblasts in adjacent (left, arrow) or distant (right) area. Scale bars = 200 μm. (B) Quantification of endothelium volume density (Vv), peritubular capillary length density (Jv), nitrotyrosine (NT)-positive tubuli, TUNEL-positive cells and Ki-67-positive cells, in renal tissues of MWF rats receiving fibroblasts or saline. Data are expressed as mean ± SE (n = 3 rats/group). (C) Representative immunohistochemical images of SMP30 (green), NCAM (red), VEGF (brown signal), FGF2 (red), HGF (red), IGF-1 (red) and Pax-2 (red) in male rats with fibroblast transplant. Sections are co-stained with rhodamine-LCA (in SMP30 panel, red) or with FITC-WGA lectin (in panels showing NCAM, FGF2, HGF, IGF-1, Pax2, green) and DAPI (blue). Scale bars = 50 μm. Image collected and cropped by CiteAb from the following open publication (https://dx.plos.org/10.1371/journal.pone.0120235), licensed under a CC-BY license. Not internally tested by R&D Systems.

Immunohistochemistry Detection of Rat VEGF by Immunohistochemistry View Larger

Detection of Rat VEGF by Immunohistochemistry Expression of mRNAs and proteins relevant to kidney regeneration in male MWF rats.(A) Real Time RT-PCR analysis of VEGF, FGF2, HGF, IGF-1 and Pax-2 in whole host renal tissues of male MWF rats receiving saline or metanephroi (MET) (in adjacent area), 6 weeks after transplantation. Data are expressed as mean ± SE; *P < 0.05, **P < 0.01 vs saline (n = 4 rats/group, VEGF n = 6 rats/group). (B) Immunohistochemical staining of VEGF (arrows) in male animals receiving saline or MET transplant, after 6 weeks. Scale bars = 50 μm. Representative immunofluorescence stainings (red) of FGF2, HGF, IGF-1 and Pax-2 in rats receiving saline or MET, on renal tissues labeled with WGA-lectin (green) and DAPI (blue). Scale bars = 50 μm, = 25 μm (for FGF2 and IGF-1). Semiquantitative analysis of immunohistochemical staining of VEGF, FGF2, HGF, IGF-1 and Pax-2 in male MWF rats receiving saline or MET. Data are expressed as mean ± SE; *P < 0.05, **P < 0.01 vs saline (n = 3/group). Image collected and cropped by CiteAb from the following open publication (https://dx.plos.org/10.1371/journal.pone.0120235), licensed under a CC-BY license. Not internally tested by R&D Systems.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Preparation and Storage

Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Loading...
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: VEGF

Vascular Endothelial Growth Factor (VEGF or VEGF-A), also known as Vascular Permeability Factor (VPF), is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the PDGF family that is characterized by the presence of eight conserved cysteine residues and a cystine knot structure. VEGF164 appears to be the most abundant and potent isoform, followed by VEGF120 and VEGF188. Rat VEGF164 is an approximately 25 kDa molecular weight protein sharing 97% aa sequence identity with corresponding regions of mouse, 88% with human and bovine, 90% with feline and equine, and 89% with canine and porcine VEGF, respectively. VEGF binds the type I transmembrane receptor tyrosine kinases VEGF R1 (also called Flt-1) and VEGF R2 (Flk-1/KDR) on endothelial cells. Although VEGF affinity is highest for binding to VEGF R1, VEGF R2 appears to be the primary mediator of VEGF angiogenic activity. Human VEGF165 binds the Semaphorin receptor, Neuropilin-1 and promotes complex formation with VEGF R2. VEGF is required during embryogenesis and functions to regulate the proliferation, migration, and survival of endothelial cells. In adults, VEGF functions mainly in wound healing and the female reproductive cycle. Pathologically, it is involved in tumor angiogenesis and vascular leakage. Circulating VEGF levels correlate with disease activity in autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and systemic lupus erythematosus. VEGF is induced by hypoxia and cytokines such as IL-1, IL-6, IL-8, Oncostatin M (OSM) and TNF-alpha.

Long Name
Vascular Endothelial Growth Factor
Entrez Gene IDs
7422 (Human); 22339 (Mouse); 83785 (Rat); 281572 (Bovine); 403802 (Canine); 493845 (Feline); 30682 (Zebrafish)
Alternate Names
MVCD1; VAS; vascular endothelial growth factor A; Vascular permeability factor; Vasculotropin; VEGF; VEGFA; VEGF-A; VEGFMGC70609; VPF; VPFvascular endothelial growth factor

Product Datasheets

You must select a language.

x

Citations for Rat VEGF Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

44 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Imaging Blood Vessels and Lymphatics in Mouse Trachea Wholemounts
    Authors: Peter Baluk, Donald M. McDonald
    Methods in Molecular Biology
  2. Vascular Endothelial Growth Factor Secretion by Nonmyocytes Modulates Connexin-43 Levels in Cardiac Organoids
    Authors: Rohin K. Iyer, Devang Odedra, Loraine L.Y. Chiu, Gordana Vunjak-Novakovic, Milica Radisic
    Tissue Engineering Part A
  3. CCN1 interlinks integrin and Hippo pathway to autoregulate tip cell activity
    Authors: Park MH, Kim AK, Manandhar S et al.
    Elife
  4. ROCK-1 mediates diabetes-induced retinal pigment epithelial and endothelial cell blebbing: Contribution to diabetic retinopathy
    Authors: Pierre-Raphaël Rothschild, Sawsen Salah, Marianne Berdugo, Emmanuelle Gélizé, Kimberley Delaunay, Marie-Christine Naud et al.
    Scientific Reports
  5. Safety of anti-VEGF treatments in a diabetic rat model and retinal cell culture


    Authors: Richard Filek, Phil Hooper, Tom G Sheidow, Hong Liu, Subrata Chakrabarti, Cindy ML Hutnik
    Clinical Ophthalmology
  6. DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma model
    Authors: Benjamin A. Hoff, Mahaveer S. Bhojani, John Rudge, Thomas L. Chenevert, Charles R. Meyer, Stefanie Galbán et al.
    NMR in Biomedicine
  7. Imaging of Therapeutic Effects of Anti-Vascular Endothelial Growth Factor Inhibitors by Optical Coherence Tomography Angiography in a Rat Model
    Authors: Johanna H. Meyer, Janine Marx, Claudine Strack, Frank G. Holz, Steffen Schmitz-Valckenberg
    Translational Vision Science & Technology
  8. A Quantitative and Standardized Method for the Evaluation of Choroidal Neovascularization Using MICRON III Fluorescein Angiograms in Rats
    Authors: Jonathan P. Wigg, Hong Zhang, Dong Yang
    PLOS ONE
  9. Mechanisms of FH Protection Against Neovascular AMD
    Authors: Céline Borras, Kimberley Delaunay, Yousri Slaoui, Toufik Abache, Sylvie Jorieux, Marie-Christine Naud et al.
    Frontiers in Immunology
  10. Imaging Lymphatics in Mouse Lungs
    Authors: Peter Baluk, Donald M. McDonald
    Methods in Molecular Biology
  11. Bradykinin Type 1 Receptor – Inducible Nitric Oxide Synthase: A New Axis Implicated in Diabetic Retinopathy
    Authors: Rahmeh Othman, Elvire Vaucher, Réjean Couture
    Frontiers in Pharmacology
  12. A novel angiopoietin-derived peptide displays anti-angiogenic activity and inhibits tumour-induced and retinal neovascularization
    Authors: G M Palmer, Z Tiran, Z Zhou, M E Capozzi, W Park, C Coletta et al.
    British Journal of Pharmacology
  13. Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS
    Authors: Ana G. Barbeito, Laura Martinez-Palma, Marcelo R. Vargas, Mariana Pehar, Nelly Mañay, Joseph S. Beckman et al.
    Neurobiology of Disease
  14. Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy
    Authors: JR Jerome, D Deliyanti, V Suphapimol, P Kolkhof, JL Wilkinson-
    International Journal of Molecular Sciences, 2023-01-25;24(3):.
    Species: Transgenic Rat
    Sample Types: Whole Tissue
    Applications: IHC
  15. Sildenafil-Induced Revascularization of Rat Hindlimb Involves Arteriogenesis through PI3K/AKT and eNOS Activation
    Authors: C Baron-Meng, A Bocquet, A Richard, AL Guihot, B Toutain, P Pacaud, C Fassot, G Loirand, D Henrion, L Loufrani
    International Journal of Molecular Sciences, 2022-05-16;23(10):.
    Species: Rat
    Sample Types: In Vivo
    Applications: Neutralization
  16. Pigment Epithelium-Derived Factor (PEDF) Receptors Are Involved in Survival of Retinal Neurons
    Authors: S Bürger, J Meng, A Zwanzig, M Beck, M Pankonin, P Wiedemann, W Eichler, JD Unterlauft
    International Journal of Molecular Sciences, 2020-12-31;22(1):.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Neutralization
  17. Cellular Mechanisms of Angiogenesis in Neonatal Rat Models of Retinal Neurodegeneration
    Authors: D Asano, M Hokazono, S Hirano, A Morita, T Nakahara
    Int J Mol Sci, 2019-09-25;20(19):.
    Species: Rat
    Sample Types: Whole Cells
    Applications: ICC
  18. Bones in human CYP26B1 deficiency and rats with hypervitaminosis A phenocopy Vegfa overexpression
    Authors: T Lind, R Lugano, AM Gustafson, M Norgård, A van Haerin, A Dimberg, H Melhus, SP Robertson, G Andersson
    Bone Rep, 2018-06-21;9(0):27-36.
    Species: Rat
    Sample Types: Whole Tissue
    Applications: IHC
  19. Myocardial infarction stabilization by cell-based expression of controlled Vascular Endothelial Growth Factor levels
    Authors: L Melly, G Cerino, A Frobert, S Cook, MN Giraud, T Carrel, HT Tevaearai, F Eckstein, B Rondelet, A Marsano, A Banfi
    J. Cell. Mol. Med., 2018-02-25;0(0):.
    Species: Rat
    Sample Types: Whole Tissue
    Applications: IHC
  20. The effect of a single anti-Vascular Endothelial Growth Factor injection on neonatal growth and organ development: In-vivo study
    Authors: S Khalili, Y Shifrin, J Pan, J Belik, K Mireskanda
    Exp. Eye Res., 2018-02-03;169(0):54-59.
    Species: Rat
    Sample Types: In Vivo
    Applications: In Vivo
  21. Genome-wide expression differences in anti-Vegf and dexamethasone treatment of inflammatory angiogenesis in the rat cornea
    Authors: P Mirabelli, A Mukwaya, A Lennikov, M Xeroudaki, B Peebo, M Schaupper, N Lagali
    Sci Rep, 2017-08-15;7(1):7616.
    Species: Rat
    Sample Types: In Vivo
    Applications: Neutralization
  22. Coronary angiogenic effect of long-term administration of Nigella sativa
    Authors: LI Al Asoom
    BMC Complement Altern Med, 2017-06-13;17(1):308.
    Species: Rat
    Sample Types: Whole Tissue
    Applications: IHC
  23. FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy.
    Authors: Deliyanti D, Zhang Y, Khong F, Berka D, Stapleton D, Kelly D, Wilkinson-Berka J
    PLoS ONE, 2015-07-29;10(7):e0134392.
    Species: Rat
    Sample Types: Whole Tissue
    Applications: IHC-P
  24. Renal primordia activate kidney regenerative events in a rat model of progressive renal disease.
    Authors: Imberti B, Corna D, Rizzo P, Xinaris C, Abbate M, Longaretti L, Cassis P, Benedetti V, Benigni A, Zoja C, Remuzzi G, Morigi M
    PLoS ONE, 2015-03-26;10(3):e0120235.
    Species: Rat
    Sample Types: Whole Tissue
    Applications: IHC
  25. Quantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity.
    Authors: Wang H, Yang Z, Jiang Y, Flannery J, Hammond S, Kafri T, Vemuri S, Jones B, Hartnett M
    Invest Ophthalmol Vis Sci, 2014-02-04;55(2):737-44.
    Species: Rat
    Sample Types: In Vivo
    Applications: Neutralization
  26. Long-term gene therapy with thrombospondin 2 inhibits TGF-beta activation, inflammation and angiogenesis in chronic allograft nephropathy.
    Authors: Daniel C, Vogelbacher R, Stief A, Grigo C, Hugo C
    PLoS ONE, 2013-12-23;8(12):e83846.
    Species: Rat
    Sample Types: Whole Tissue
    Applications: IHC
  27. Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity.
    Authors: McCloskey M, Wang H, Jiang Y, Smith G, Strange J, Hartnett M
    Invest Ophthalmol Vis Sci, 2013-03-21;54(3):2020-6.
    Species: Rat
    Sample Types: In Vivo
    Applications: Neutralization
  28. The probiotic mixture VSL#3 accelerates gastric ulcer healing by stimulating vascular endothelial growth factor.
    Authors: Dharmani P, De Simone C, Chadee K
    PLoS ONE, 2013-03-06;8(3):e58671.
    Species: Rat
    Sample Types: Whole Tissue
    Applications: Neutralization
  29. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
    Authors: Westenbrink BD, Ruifrok WP, Voors AA
    Cardiovasc. Res., 2010-02-05;87(1):30-9.
    Species: Rat
    Sample Types: In Vivo, Whole Cells
    Applications: Neutralization
  30. Production of scFv antibody fragments from a hybridoma with functional activity against human vascular endothelial growth factor.
    Authors: Irani Y, Brereton HM, Tilton RG
    Hybridoma (Larchmt), 2009-06-01;28(3):205-9.
    Species: Human, Mouse, Rat
    Sample Types: Recombinant Protein
    Applications: Binding Assay
  31. Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1.
    Authors: Lin HH, Chen YH, Chang PF, Lee YT, Yet SF, Chau LY
    J. Mol. Cell. Cardiol., 2008-05-02;45(1):44-55.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  32. VEGF promotes vascular sympathetic innervation.
    Authors: Marko SB, Damon DH
    Am. J. Physiol. Heart Circ. Physiol., 2008-04-11;294(6):H2646-52.
    Species: Rat
    Sample Types: In Vivo, Whole Cells, Whole Tissue
    Applications: ICC, IHC-Fr, Neutralization
  33. Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease.
    Authors: Hartnett ME, Martiniuk D, Byfield G, Geisen P, Zeng G, Bautch VL
    Invest. Ophthalmol. Vis. Sci., 2008-03-31;49(7):3107-14.
    Species: Rat
    Sample Types: In Vivo
    Applications: Neutralization
  34. Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia.
    Authors: Yeh WL, Lin CJ, Fu WM
    Mol. Pharmacol., 2007-10-17;73(1):170-7.
    Species: Rat
    Sample Types: Cell Culture Supernates
    Applications: Neutralization
  35. Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions.
    Authors: Advani A, Kelly DJ, Advani SL, Cox AJ, Thai K, Zhang Y, White KE, Gow RM, Marshall SM, Steer BM, Marsden PA, Rakoczy PE, Gilbert RE
    Proc. Natl. Acad. Sci. U.S.A., 2007-08-28;104(36):14448-53.
    Species: Rat
    Sample Types: In Vivo
    Applications: Neutralization
  36. Effects of red wine polyphenols on postischemic neovascularization model in rats: low doses are proangiogenic, high doses anti-angiogenic.
    Authors: Baron-Menguy C, Bocquet A, Guihot AL, Chappard D, Amiot MJ, Andriantsitohaina R, Loufrani L, Henrion D
    FASEB J., 2007-06-26;21(13):3511-21.
    Species: Rat
    Sample Types: In Vivo
    Applications: Neutralization
  37. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression.
    Authors: Yeh WL, Lu DY, Lin CJ, Liou HC, Fu WM
    Mol. Pharmacol., 2007-05-18;72(2):440-9.
    Species: Rat
    Sample Types: Whole Cells
    Applications: Neutralization
  38. Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy.
    Authors: Shimojo N, Jesmin S, Zaedi S, Otsuki T, Maeda S, Yamaguchi N, Aonuma K, Hattori Y, Miyauchi T
    Am. J. Physiol. Heart Circ. Physiol., 2007-03-16;293(1):H474-81.
    Species: Rat
    Sample Types: Whole Cells
    Applications: Neutralization
  39. Motor neurons use push-pull signals to direct vascular remodeling critical for their connectivity
    Authors: Luis F. Martins, Ilaria Brambilla, Alessia Motta, Stefano de Pretis, Ganesh Parameshwar Bhat, Aurora Badaloni et al.
    Neuron
  40. Tissue engraftment of hypoxic-preconditioned adipose-derived stem cells improves flap viability
    Authors: Scott T. Hollenbeck, Annika Senghaas, Issei Komatsu, Ying Zhang, Detlev Erdmann, Bruce Klitzman
    Wound Repair and Regeneration
  41. Designer Leptin Receptor Antagonist Allo-aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models
    Authors: Roberta Coroniti, Rafal Fario, Didier J. Nuno, Laszlo Otvos, Laura Scolaro, Eva Surmacz
    Frontiers in Molecular Biosciences
  42. Vascular Endothelial Growth Factor and Spinal Cord Injury Pain
    Authors: Olivera Nesic, Laura M. Sundberg, Juan J. Herrera, Venkata U.L. Mokkapati, Julieann Lee, Ponnada A. Narayana
    Journal of Neurotrauma
  43. Evaluation of potential activity of luseogliflozin on vascular proliferation in the mesenteric lymph node with or without vascular tumors in Sprague-Dawley rats in a carcinogenicity study
    Authors: Minoru Sasaki, Takanobu Sakurai, Aiko Ishii, Kenta Matsue, Yutaka Nakanishi, Shunsuke Tsutsumi et al.
    Journal of Toxicologic Pathology
  44. Ginsenoside RG1 enhances the paracrine effects of bone marrow-derived mesenchymal stem cells on radiation induced intestinal injury
    Authors: Yujun Luo, Beibei Wang, Jianhua Liu, Faxin Ma, Dongling Luo, Zhongwen Zheng et al.
    Aging (Albany NY)

FAQs

No product specific FAQs exist for this product, however you may

View all Antibody FAQs
Loading...

Reviews for Rat VEGF Antibody

There are currently no reviews for this product. Be the first to review Rat VEGF Antibody and earn rewards!

Have you used Rat VEGF Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review